🔎 Trials Near Me

Utama › Sistem Imun dan Gangguan › New York

Kajian klinikal Sistem Imun dan Gangguan di New York

14 kajian untuk Sistem Imun dan Gangguan sedang mencari peserta di lokasi di New York.

Bandar di New York

Teks kajian rasmi (Bahasa Inggeris)

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

  • Memorial Sloan Kettering Cancer Center, New York
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07192471

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Memorial Sloan Kettering Cancer Center, New York
  • Montefiore Medical Center, The Bronx
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT06722235

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

  • Hematology Oncology Associates of Central New York-Auburn, Auburn
  • Roswell Park Cancer Institute, Buffalo
  • Hematology Oncology Associates of CNY at Camillus, Camillus
  • dan 5 lagi
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 17 Sep 2026 · NCT04242095

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Memorial Sloan Kettering Cancer Center, New York
  • Montefiore Medical Center, The Bronx
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06948318

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
  • Montefiore Medical Center, The Bronx
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT05826535

Abatacept for the Treatment of Giant Cell Arteritis

  • Hospital for Special Surgery, New York
Mengambil pesertaFasa 3
Umur 50 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT04474847

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

  • NY Nephrology, Clifton Park
  • Icahn School of Medicine at Mount Sinai, New York
Mengambil pesertaFasa 3
Umur 18 hingga 100 · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT06858319

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

  • Inmagene Site 6, Kew Gardens
  • Inmagene Site 21, New York
  • Inmagene Site 11, Woodbury
Mengambil pesertaFasa 2
Umur 18 hingga 74 · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT07037901

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

  • Weill Cornell Medicine - New York Presbyterian Hospital, New York
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT07216443

A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition

  • Columbia University Irving Medical Center, New York
Mengambil pesertaFasa 2
Semua umur · Semua jantina · Dikemas kini 2 Jun 2026 · NCT05787574

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • Mt Sinai, New York
  • Memorial Sloan Kettering Cancer Center, New York
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Apr 2026 · NCT03328078

Biologics And Clinical Immunology Cohort at Sinai

  • Mount Sinai, New York
Mengambil pesertaKajian pemerhatian
Umur 12 ke atas · Semua jantina · Dikemas kini 17 Feb 2026 · NCT04784364

BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma

  • Sun River Health, Beacon
  • Bedford Stuyvesant Family Health Center, Brooklyn
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Jan 2026 · NCT05341726

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.